Effect of oral vitamin D on serum pro-B- type natriuretic peptide in peritoneal dialysis patients.

Not Applicable

• Conditions: end stage renal disease.; Chronic kidney disease, stage 5

• Registration Number: IRCT201303252417N12
• Lead Sponsor: Vice Chancellor for Research, Isfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 84

Inclusion Criteria

1- Minimum duration of peritoneal dialysis for 3 months. 2- No treatment with vitamin D. 3- Patient satisfaction.
Exclusion criteria: 1- History of malignancy. 2- History of myocardial infarction or heart failure in 3 months ago. 3- Serum level of vitamin D more than 30ng/m. 4- Calcium-phosphorus product more than 55.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Serum vitamin D level. Timepoint: Baseline, at the end of the study. Method of measurement: ng/mL.;Adequacy of dialysis. Timepoint: Baseline, at the end of the study. Method of measurement: software.;Serum Pro BNP level. Timepoint: Baseline, at the end of the study. Method of measurement: pg/mL.

Secondary Outcome Measures

Name	Time	Method
Serum calcium level. Timepoint: Baseline, at the end of the study. Method of measurement: mg/dL.;Serum Parathormon level. Timepoint: Baseline, at the end of the study. Method of measurement: pg/dL.